Tokyo Tape
Sign in
← Nitto Boseki

Half-year report · HY

3110.TEDINET S100WZ3X
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥57.4bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥109.0bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥53.1bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥9.5bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥7.3bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥9.2bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥17.6bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.7bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥9.2bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥7.7bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥6.9bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥12.8bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.4bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥7.0bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥5.6bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥238.6bnat 2025-09-30Cons.Assets
Total assets¥223.1bnat 2025-03-31Cons.Assets
Total assets¥211.3bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥96.1bnat 2025-09-30Cons.Liabilities
Total liabilities¥87.3bnat 2025-03-31Cons.Liabilities
Net assets / equity¥142.6bnat 2025-09-30Cons.Net assets
Net assets / equity¥135.8bnat 2025-03-31Cons.Net assets
Net assets / equity¥130.4bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥29.5bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥28.5bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥29.3bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥28.4bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥22.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥23.5bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥7.1bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥19.1bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥10.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥7.3bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥11.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥5.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥799m2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.3bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥188.942025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥352.612024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥148.632024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio57.1%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio58.1%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.8%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥10.3bn
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥10.3bn
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥775m
Composite Materials Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥7.4bn
Composite Materials Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥6.9bn
Composite Materials Businessreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥529m
Composite Materials Businessreportable segmentsegment profit2025-04-01 → 2025-09-30−¥137m
Electronic Materials Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥29.6bn
Electronic Materials Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥23.4bn
Electronic Materials Businessreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥6.2bn
Electronic Materials Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥9.0bn
Insulation Materials Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥7.3bn
Insulation Materials Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥7.3bn
Insulation Materials Businessreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥12m
Insulation Materials Businessreportable segmentsegment profit2025-04-01 → 2025-09-30−¥209m
Materials And Chemicals Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥5.6bn
Materials And Chemicals Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥4.5bn
Materials And Chemicals Businessreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥1.0bn
Materials And Chemicals Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥224m
Medical Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥6.8bn
Medical Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥6.8bn
Medical Businessreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥19m
Medical Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.1bn
Other Businessesreportable segmentrevenue2025-04-01 → 2025-09-30¥11.1bn
Other Businessesreportable segmentrevenue external2025-04-01 → 2025-09-30¥8.6bn
Other Businessesreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥2.6bn
Other Businessesreportable segmentsegment profit2025-04-01 → 2025-09-30¥279m
—segment totalrevenue2025-04-01 → 2025-09-30¥67.8bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥57.4bn
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥10.3bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥10.2bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥8.6bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥8.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥595m
Composite Materials Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥7.0bn
Composite Materials Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥6.5bn
Composite Materials Businessreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥506m
Composite Materials Businessreportable segmentsegment profit2024-04-01 → 2024-09-30−¥668m
Electronic Materials Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥25.1bn
Electronic Materials Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥19.6bn
Electronic Materials Businessreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥5.5bn
Electronic Materials Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥6.4bn
Insulation Materials Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥7.6bn
Insulation Materials Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥7.5bn
Insulation Materials Businessreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥18m
Insulation Materials Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥352m
Materials And Chemicals Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥5.6bn
Materials And Chemicals Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥4.5bn
Materials And Chemicals Businessreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥1.0bn
Materials And Chemicals Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥268m
Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥7.0bn
Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥7.0bn
Medical Businessreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥15m
Medical Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.4bn
Other Businessesreportable segmentrevenue2024-04-01 → 2024-09-30¥9.4bn
Other Businessesreportable segmentrevenue external2024-04-01 → 2024-09-30¥7.8bn
Other Businessesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥1.5bn
Other Businessesreportable segmentsegment profit2024-04-01 → 2024-09-30¥213m
—segment totalrevenue2024-04-01 → 2024-09-30¥61.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥53.1bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥8.6bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥7.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 532
ItemContextValueUnit
Income taxes payableInterimInstant1937000000JPY
Provision for bonusesPrior1YearInstant2331000000JPY
Provision for bonusesInterimInstant2392000000JPY
Other clPrior1YearInstant9185000000JPY
Other clInterimInstant12328000000JPY
Current liabilitiesPrior1YearInstant40142000000JPY
Current liabilitiesInterimInstant45633000000JPY
Bonds payablePrior1YearInstant10000000000JPY
Bonds payableInterimInstant10000000000JPY
Long term loans payablePrior1YearInstant23743000000JPY
Long term loans payableInterimInstant26121000000JPY
Lease obligations nclPrior1YearInstant882000000JPY
Lease obligations nclInterimInstant774000000JPY
Provision for repairs nclPrior1YearInstant4802000000JPY
Provision for repairs nclInterimInstant4846000000JPY
Provision for share based remuneration for directors and other officers nclPrior1YearInstant119000000JPY
Provision for share based remuneration for directors and other officers nclInterimInstant146000000JPY
Net defined benefit liabilityPrior1YearInstant4978000000JPY
Net defined benefit liabilityInterimInstant4797000000JPY
Other nclPrior1YearInstant2607000000JPY
Other nclInterimInstant3734000000JPY
Noncurrent liabilitiesPrior1YearInstant47134000000JPY
Noncurrent liabilitiesInterimInstant50421000000JPY
LiabilitiesPrior1YearInstant87276000000JPY
LiabilitiesInterimInstant96054000000JPY
Capital stockPrior1YearInstant19699000000JPY
Capital stockInterimInstant19699000000JPY
Capital surplusPrior1YearInstant19373000000JPY
Capital surplusInterimInstant19373000000JPY
Retained earningsPrior1YearInstant78567000000JPY
Retained earningsInterimInstant82574000000JPY
Treasury stockPrior1YearInstant-3028000000JPY
Treasury stockInterimInstant-3031000000JPY
Shareholders equityPrior1YearInstant114612000000JPY
Shareholders equityInterimInstant118616000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant6797000000JPY
Valuation difference on available for sale securitiesInterimInstant9416000000JPY
Foreign currency translation adjustmentPrior1YearInstant7633000000JPY
Foreign currency translation adjustmentInterimInstant7525000000JPY
Remeasurements of defined benefit plansPrior1YearInstant690000000JPY
Remeasurements of defined benefit plansInterimInstant635000000JPY
Valuation and translation adjustmentsPrior1YearInstant15122000000JPY
Valuation and translation adjustmentsInterimInstant17577000000JPY
Non controlling interestsPrior1YearInstant6095000000JPY
Non controlling interestsInterimInstant6360000000JPY
Net assetsPrior1YearInstant135829000000JPY
Net assetsInterimInstant142553000000JPY
Liabilities and net assetsPrior1YearInstant223105000000JPY
Liabilities and net assetsInterimInstant238608000000JPY
Net salesPrior1InterimDuration53051000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass